Protalix BioTherapeutics (PLX) Cash from Operations Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 85.14% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 74.39% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.23% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 158.60% |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn | 535.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 535.45% |
| Dec 31, 2025 | -49.14% |
| Sep 30, 2025 | -190.91% |
| Jun 30, 2025 | -44.96% |
| Mar 31, 2025 | -220.77% |
| Dec 31, 2024 | 11.02% |
| Sep 30, 2024 | 159.60% |
| Jun 30, 2024 | -172.59% |
| Mar 31, 2024 | 239.69% |
| Dec 31, 2023 | 237.69% |
| Sep 30, 2023 | 25.16% |
| Jun 30, 2023 | 167.60% |
| Mar 31, 2023 | 48.57% |
| Dec 31, 2022 | 48.67% |
| Sep 30, 2022 | -389.57% |
| Jun 30, 2022 | -212.89% |
| Mar 31, 2022 | 40.73% |
| Dec 31, 2021 | 32.62% |
| Sep 30, 2021 | 47.84% |
| Jun 30, 2021 | 183.17% |
| Mar 31, 2021 | -38.18% |
| Dec 31, 2020 | -104.77% |
| Sep 30, 2020 | -11.75% |
| Jun 30, 2020 | -51.55% |
| Mar 31, 2020 | 2.19% |
| Dec 31, 2019 | 7.92% |
| Sep 30, 2019 | -123.65% |
| Jun 30, 2019 | 35.08% |
| Mar 31, 2019 | 22.70% |
| Dec 31, 2018 | -122.61% |
| Sep 30, 2018 | 228.01% |
| Jun 30, 2018 | 6.27% |
| Mar 31, 2018 | -10.12% |
| Dec 31, 2017 | 340.93% |
| Sep 30, 2017 | -210.46% |
| Jun 30, 2017 | 29.48% |
| Mar 31, 2017 | 7.77% |
| Dec 31, 2016 | -37.54% |
| Sep 30, 2016 | 65.35% |
| Jun 30, 2016 | -176.73% |
| Mar 31, 2016 | -50.28% |
| Mar 31, 2015 | 26.06% |
| Mar 31, 2014 | 13.00% |
| Dec 31, 2013 | 5.11% |
| Sep 30, 2013 | -2.33% |
| Jun 30, 2013 | -161.79% |
| Mar 31, 2013 | -52.62% |
| Dec 31, 2012 | 127.54% |
| Sep 30, 2012 | 1.45% |
| Jun 30, 2012 | 372.11% |
| Mar 31, 2012 | -57.50% |
| Dec 31, 2011 | 17.67% |
| Sep 30, 2011 | 15.84% |